Laurion Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Laurion Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-45,000	Closed	-$4.34M	–	1050
2018 Q4	$4.34M	Hold	45,000	–	–	0.08%	318
2018 Q3	$5.49M	Hold	45,000	–	–	0.05%	327
2018 Q2	$4.94M	Hold	45,000	–	–	0.04%	353
2018 Q1	$4.8M	Hold	45,000	–	–	0.04%	377
2017 Q4	$4.8M	Hold	45,000	–	–	0.02%	526
2017 Q3	$5M	Hold	45,000	–	–	0.02%	509
2017 Q2	$4.65M	Buy	+45,000	New	+$4.43M	0.03%	533
2015 Q3	–	Sell	-150,000	Closed	-$18.4M	–	810
2015 Q2	$18.4M	Buy	150,000 +90,000	+150%	+$10.8M	0.17%	146
2015 Q1	$6.87M	Buy	+60,000	New	+$6.62M	0.13%	141

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Laurion Capital Management's IBB Position: Q1 2019 in Review

Laurion Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 17,399 shares — an estimated $1.68M sold.

Laurion Capital Management first reported a position in IBB in Q2 2017 and held it in 6 quarters. The position peaked at $1.68M in Q4 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Laurion Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
Laurion Capital Management sold 17,399 iShares Biotechnology ETF shares in Q1 2019, an estimated $1.68M.
Laurion Capital Management first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 6 quarters.
Laurion Capital Management's iShares Biotechnology ETF position peaked at $1.68M in Q4 2018.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Laurion Capital Management's 13F filing for Q1 2019, filed 8 May 2019.